Recommended in Pharmacists

  • Clinical Essentials from MMWR Morb Mortal Wkly Rep
  • 1 comment
  • FULLTEXT

CDC: influenza vaccine 48% effective this season

Results of an interim analysis in the Morbidity and Mortality Weekly Report.

Read more
  • Clinical Essentials from Cancer
  • 1 comment

CML: smoking identified as an unfavorable prognostic factor

Read more
  • Clinical Essentials from Aliment Pharmacol Ther
  • 1 comment

HCV: study supports DAA-related risk for HBV reactivation

Read more
  • Clinical Essentials from Clin Pharmacokinet
  • 1 comment

New insulin aspart formulation works faster, clears out sooner

Read more
  • The Lancet Infectious Diseases
  • 1 comment
  • FULLTEXT

Global antibiotic stewardship collaboration in five countries

Read more
  • Univadis Medical News
  • 1 comment

European Commission warns of health risks with UV-C hospital equipment sterilisation process

Read more
  • Clinical Essentials from Gastroenterology
  • 1 comment

HCV: 6-trial analysis confirms EBR/GZR efficacy in compensated cirrhosis

Read more
  • Clinical Essentials from Transl Pediatr
  • 1 comment
  • FULLTEXT

HIV: fetal/neonatal NRTI exposure linked to developmental delay, behavioral disorders

Read more
  • Monthly Essentials
  • 1 comment

Asthma and COPD: Monthly Essentials February 2017

Read more

Professional & Business

  • International Medical Press

GPs told to ration stop smoking services

Read more
  • International Medical Press

NHS at ‘breaking point’, warns BMA

Read more
  • International Medical Press

Researchers blame health care cuts for mortality rise

Read more
  • International Medical Press

Ten million GP appointments wasted each year

Read more
  • International Medical Press

Thousands of new mothers have no access to midwives

Read more
  • International Medical Press

Researchers call for vitamin D food fortification

Read more
View more

New in Pharmacists

  • Clinical Essentials from Oncotarget
  • no comment

Breast cancer: how safe is dual HER2 blockade?

Results of a meta-analysis.

Read more
  • Clinical Essentials from Lancet Neurol
  • 1 comment

Acute optic neuritis: opicinumab may improve remyelination

Current therapies for optic neuritis and multiple sclerosis do not repair neuronal damage.

Read more
  • Clinical Essentials from Lancet Neurol
  • 1 comment

MS: alemtuzumab, natalizumab similarly effective for reducing relapse

Results of a longitudinal cohort study in 23 countries.

Read more
Abnormal vaginal microbiota not a bar to effective oral PrEP | CROI
  • Conference reports - RSi Communications
  • 1 comment

Abnormal vaginal microbiota not a bar to effective oral PrEP | CROI

PrEP efficacy did not differ among women with detected versus undetected Gardnerella/Bacteroides and Lactobacillus.

Read more
Opioid abuse: CDC finds increase among black MSM and those of low SES | CROI
  • Conference reports - RSi Communications
  • 1 comment

Opioid abuse: CDC finds increase among black MSM and those of low SES | CROI

MSM have higher rates of drug use and are at increased risk of contracting HIV.

Read more
Lipids and CAD: Monthly Essentials February 2017
  • Monthly Essentials
  • 1 comment

Lipids and CAD: Monthly Essentials February 2017

Evolocumab and CV risk | New dyslipidemia guidelines | Family history predicts subclinical CAD

Read more
  • Clinical Essentials from J Acquir Immune Defic Syndr
  • 1 comment

HIV: markers of inflammation remain elevated despite early ART initiation

Early ART has been proposed as a strategy to prevent persistent HIV-associated inflammation.

Read more
  • Clinical Essentials from Clinicoecon Outcomes Res
  • 1 comment

MS-related healthcare needs fall sharply after initiation of natalizumab

Study shows sharp drop in hospitalizations, corticosteroid use, sick days, and associated costs.

Read more
  • Clinical Essentials from J Alzheimers Dis
  • 1 comment

Parkinson's disease: add-on zonisamide yields benefit

Meta-analysis shows reduced motor impairment and “off” time.

Read more
  • Clinical Essentials from J Urol
  • 1 comment

Refractory IC/BPS: intravesical lipotoxin fails to show benefit

Results of a multicenter, randomized controlled clinical trial.

Read more
  • Clinical Essentials from Ther Adv Med Oncol
  • 1 comment

NPC: second-line nedaplatin plus S-1 shows promise

Study shows 42.3% overall response rate.

Read more
  • Clinical Essentials from Diabetes Care
  • 1 comment

Lixisenatide may benefit older adults with type 2 diabetes

The highest prevalence of T2D is among those aged 70-79 y.

Read more
  • Clinical Essentials from Medicine (Baltimore)
  • 1 comment

Etanercept associated with reduced cancer risk in RA

Biologic-naïve patients had higher cancer rates in this large cohort study.

Read more
  • Clinical Essentials from Neurology
  • 1 comment

Does hormone replacement therapy reduce risk for dementia in menopausal women?

Studies on protection from AD in menopausal women using hormonal therapy have been inconsistent.

Read more